Sort by

Send to

Choose Destination

Search results

Items: 19


Nicorandil, a Nitric Oxide Donor and ATP-Sensitive Potassium Channel Opener, Protects Against Dystrophin-Deficient Cardiomyopathy.

Afzal MZ, Reiter M, Gastonguay C, McGivern JV, Guan X, Ge ZD, Mack DL, Childers MK, Ebert AD, Strande JL.

J Cardiovasc Pharmacol Ther. 2016 Mar 2. pii: 1074248416636477. [Epub ahead of print]


Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction.

Raphael R, Purushotham D, Gastonguay C, Chesnik MA, Kwok WM, Wu HE, Shah SJ, Mirza SP, Strande JL.

J Transl Med. 2016 Jan 20;14:18. doi: 10.1186/s12967-016-0774-3.


Haploinsufficiency MYBPC3 mutations: another stress induced cardiomyopathy? Let's take a look!

Strande JL.

J Mol Cell Cardiol. 2015 Feb;79:284-6. doi: 10.1016/j.yjmcc.2014.12.008. Epub 2014 Dec 16. No abstract available.


Sucrose non-fermenting related kinase enzyme is essential for cardiac metabolism.

Cossette SM, Gastonguay AJ, Bao X, Lerch-Gaggl A, Zhong L, Harmann LM, Koceja C, Miao RQ, Vakeel P, Chun C, Li K, Foeckler J, Bordas M, Weiler H, Strande J, Palecek SP, Ramchandran R.

Biol Open. 2014 Dec 12;4(1):48-61. doi: 10.1242/bio.20149811.


Whole-thorax irradiation induces hypoxic respiratory failure, pleural effusions and cardiac remodeling.

Medhora M, Gao F, Glisch C, Narayanan J, Sharma A, Harmann LM, Lawlor MW, Snyder LA, Fish BL, Down JD, Moulder JE, Strande JL, Jacobs ER.

J Radiat Res. 2015 Mar;56(2):248-60. doi: 10.1093/jrr/rru095. Epub 2014 Nov 3.


Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.

Guan X, Mack DL, Moreno CM, Strande JL, Mathieu J, Shi Y, Markert CD, Wang Z, Liu G, Lawlor MW, Moorefield EC, Jones TN, Fugate JA, Furth ME, Murry CE, Ruohola-Baker H, Zhang Y, Santana LF, Childers MK.

Stem Cell Res. 2014 Mar;12(2):467-80. doi: 10.1016/j.scr.2013.12.004. Epub 2013 Dec 23.


Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts.

Sonin DL, Wakatsuki T, Routhu KV, Harmann LM, Petersen M, Meyer J, Strande JL.

J Cardiovasc Pharmacol Ther. 2013 Sep;18(5):460-75. doi: 10.1177/1074248413485434. Epub 2013 Apr 17.


Nerve growth factor reduces myocardial ischemia/reperfusion injury in rat hearts.

Strande JL, Routhu KV, Lecht S, Lazarovici P.

J Basic Clin Physiol Pharmacol. 2013;24(1):81-4. doi: 10.1515/jbcpp-2012-0045.


Parstatin(1-26): the putative signal peptide of protease-activated receptor 1 confers potent protection from myocardial ischemia-reperfusion injury.

Routhu KV, Tsopanoglou NE, Strande JL.

J Pharmacol Exp Ther. 2010 Mar;332(3):898-905. doi: 10.1124/jpet.109.162602. Epub 2009 Dec 15.


Gadolinium decreases inflammation related to myocardial ischemia and reperfusion injury.

Strande JL, Routhu KV, Hsu A, Nicolosi AC, Baker JE.

J Inflamm (Lond). 2009 Dec 10;6:34. doi: 10.1186/1476-9255-6-34.


10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model.

Baker JE, Fish BL, Su J, Haworth ST, Strande JL, Komorowski RA, Migrino RQ, Doppalapudi A, Harmann L, Allen Li X, Hopewell JW, Moulder JE.

Int J Radiat Biol. 2009 Dec;85(12):1089-100. doi: 10.3109/09553000903264473.


Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.

Strande JL, Widlansky ME, Tsopanoglou NE, Su J, Wang J, Hsu A, Routhu KV, Baker JE.

Cardiovasc Res. 2009 Jul 15;83(2):325-34. doi: 10.1093/cvr/cvp122. Epub 2009 Apr 20.


Thrombin increases inflammatory cytokine and angiogenic growth factor secretion in human adipose cells in vitro.

Strande JL, Phillips SA.

J Inflamm (Lond). 2009 Mar 6;6:4. doi: 10.1186/1476-9255-6-4.


Letter by Strande regarding article "Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy".

Strande JL.

Circulation. 2008 Jun 17;117(24):e495; author reply e496. doi: 10.1161/CIRCULATIONAHA.107.758219. No abstract available.


Gadolinium limits myocardial infarction in the rat: dose-response, temporal relations and mechanisms.

Nicolosi AC, Strande JL, Hsu A, Fu X, Su J, Gross GJ, Baker JE.

J Mol Cell Cardiol. 2008 Feb;44(2):345-51. Epub 2007 Nov 19.


Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling.

Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE.

J Pharmacol Exp Ther. 2008 Mar;324(3):1045-54. Epub 2007 Nov 30.


Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats.

Baker JE, Su J, Hsu A, Shi Y, Zhao M, Strande JL, Fu X, Xu H, Eis A, Komorowski R, Jensen ES, Tweddell JS, Rafiee P, Gross GJ.

Cardiovasc Res. 2008 Jan;77(1):44-53. Epub 2007 Sep 22.


SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.

Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE.

Basic Res Cardiol. 2007 Jul;102(4):350-8. Epub 2007 Apr 30.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk